BAMCO Inc
KYMR icon

BAMCO Inc’s Kymera Therapeutics KYMR Stock Holding History

BAMCO Inc’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.29M Hold
20,000
– – ﹤0.01% 281
2026
Q1 		$1.67M Hold
20,000
– – 0.01% 282
2025
Q4 		$1.56M Buy
20,000
+13,000
+186% +$878K ﹤0.01% 288
2025
Q3 		$396K Buy
+7,000
New +$316K ﹤0.01% 321
2025
Q1 		– Sell
-25,000
Closed -$1.01M – 327
2024
Q4 		$1.01M Hold
25,000
– – ﹤0.01% 291
2024
Q3 		$1.18M Buy
+25,000
New +$1.1M ﹤0.01% 298

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BAMCO Inc's KYMR Position: Q2 2026 in Review

BAMCO Inc held its Kymera Therapeutics (KYMR) position steady in Q2 2026 at 20,000 shares worth $2.29M. The position accounts for ﹤0.01% of the portfolio, ranked #281.

BAMCO Inc first reported a position in KYMR in Q3 2024 and has held it in 6 quarters since. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • BAMCO Inc held 20,000 shares of Kymera Therapeutics worth $2.29M as of Q2 2026.
  • BAMCO Inc left its Kymera Therapeutics share count unchanged in Q2 2026.
  • Kymera Therapeutics made up ﹤0.01% of BAMCO Inc's portfolio in Q2 2026, its #281 holding.
  • BAMCO Inc first reported a position in Kymera Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on BAMCO Inc's 13F filing for Q2 2026, filed 14 Aug 2026.